Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Eton Pharmaceuticals (ETON) Treasury Shares (2020 - 2024)

Eton Pharmaceuticals' Treasury Shares history spans 4 years, with the latest figure at $226068.0 for Q4 2024.

  • For Q4 2024, Treasury Shares fell 17.55% year-over-year to $226068.0; the TTM value through Dec 2024 reached $226068.0, down 17.55%, while the annual FY2024 figure was $226068.0, 17.55% down from the prior year.
  • Treasury Shares for Q4 2024 was $226068.0 at Eton Pharmaceuticals, down from $274204.0 in the prior quarter.
  • Across five years, Treasury Shares topped out at $369606.0 in Q3 2022 and bottomed at $7595.0 in Q4 2020.
  • The 4-year median for Treasury Shares is $274204.0 (2023), against an average of $249415.8.
  • The largest annual shift saw Treasury Shares decreased 25.81% in 2023 before it fell 17.55% in 2024.
  • A 4-year view of Treasury Shares shows it stood at $7595.0 in 2020, then surged by 4766.44% to $369606.0 in 2022, then fell by 25.81% to $274204.0 in 2023, then dropped by 17.55% to $226068.0 in 2024.
  • Per Business Quant, the three most recent readings for ETON's Treasury Shares are $226068.0 (Q4 2024), $274204.0 (Q4 2023), and $369606.0 (Q4 2022).